U18666A inhibits intracellular cholesterol transport and neurotransmitter release in human neuroblastoma cells

Neurochemical Research

Volumn 24, Issue 1, 1999, Pages 69-78

  Sparrow, Susan M ^a   Carter, Jodi M ^a   Ridgway, Neale D ^a   Cook, Harold W ^a   Byers, David M ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Cholesterol; Neuroblastoma; Niemann Pick C disease; Norepinephrine; SH SY5Y; U18666A

Indexed keywords

3BETA (2 DIETHYLAMINOETHOXY)ANDROST 5 EN 17 ONE;

ARTICLE; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; COMPETITIVE INHIBITION; CYTOARCHITECTURE; DRUG EFFECT; HUMAN; HUMAN CELL; HYDROPHOBICITY; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA CELL; NEUROTRANSMITTER RELEASE; NORADRENALIN RELEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR DOWN REGULATION;

BACTERIA (MICROORGANISMS);

EID: 0032935277     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020932130753     Document Type: Article

References (47)

1. Liscum, L. and Underwood, K. W. 1995. Intracellular cholesterol transport and compartmentation. J. Biol. Chem. 270: 15443-15446.
2. Schroeder, F., Frolov, A. A., Murphy, E. J., Atshaves, B. P., Jefferson, J. R., Pu, L. X., Wood, W. G., Foxworth, W. B., and Kier, A. B. 1996. Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking. Proc. Soc. Exp. Biol. Med. 213:150-177.
3. Lange, Y. and Steck, T. L. 1996. The role of intracellular cholesterol transport in cholesterol homeostasis. Trends Cell Biol. 6: 205-208.
4. Morell, P. and Jurevics, H. 1996. Origin of cholesterol in myelin. Neurochem. Res. 21:463-470.
5. Pardridge, W. M. and Mietus, L. J. 1980. Palmitate and cholesterol transport through the blood-brain barrier. J. Neurochem. 34:463-466.
6. Posse de Chaves, E. I., Rusinol, A. E., Vance, D. E., Campenot, R. B., and Vance, J. E. 1997. Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. J. Biol. Chem. 272: 30766-30773.
7. Spence, M. W. and Callahan, J. W. 1989. Sphingomyelin-cholesterol lipidoses: the Niemann-Pick group of diseases. Pages 1655-1676, in Scriver, C. R., Baudet, A. L., Sly, W. S., and Valle, D., (eds.) The metabolic basis of inherited disease, McGraw-Hill, New York.
8. Pentchev, P. G., Vanier, M. T., Suzuki, K., and Patterson, M. C. 1995. Niemann-Pick disease type C: a cellular cholesterol lipidosis. Pages 2625-2639, in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D., (eds.) Metabolic basis of inherited disease, McGraw-Hill, New York.
9. Liscum, L. and Faust, J. R. 1987. Low density lipoprotein (LDL)-mediated suppression of cholesterol synthesis and LDL uptake is defective in Niemann-Pick type C fibroblasts. J. Biol. Chem. 262: 17002-17008.
10. Pentchev, P. G., Comly, M. E., Kruth, H. S., Tokoro, T., Butler, J., Sokol, J., Filling-Katz, M., Quirk, J. M., Marshall, D. C., Patel, S., Vanier, M. T., and Brady, R. O. 1987. Group C Niemann-Pick disease: faulty regulation of low density lipoprotein uptake and cholesterol storage in cultured fibroblasts. FASEB J. 1:40-45.
11. Pentchev, P. G., Comly, M. E., Kruth, H. S., Vanier, M. T., Wenger, D. A., Patel, S., and Brady, R. O. 1985. A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc. Natl. Acad. Sci. USA 82:8247-8251.
12. Liscum, L., Ruggiero, R. M., and Faust, J. R. 1989. The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts. J. Cell Biol. 108: 1625-1636.
13. Carstea, E. D., Morris, J. A., Coleman, K. G., Loftus, S. K., Zhang, D., Cummings, C., Gu, J., Rosenfeld, M. A., Pavan, W. J., Krizman, D. B., Nagle, J., Polymeropoulos, M. H., Sturley, S. L., Ioannou, Y. A., Higgins, M. E., Comly, M., Cooney, A., Brown, A., Kaneski, C. R., Blanchette-Mackie, E. J., Dwyer, N. K., Neufeld, E. B., Chang, T. Y., and Liscum, L. 1997. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277:228-231.
14. Liscum, L. and Faust, J. R. 1989. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in CHO cells cultured with 3-β-[2-(diethylamino)ethoxy]androst-5-en-17-one. J. Biol. Chem. 264:11796-11806.
15. Butler, J. D., Blanchette-Mackie, J., Goldin, E., O'Neill, R. R., Carstea, G., Roff, C. F., Patterson, M. C., Patel, S., Comly, M. E., Cooney, A., Vanier, M. T., Brady, R. O., and Pentchev, P. G. 1992. Progesterone blocks cholesterol translocation from lysosomes. J. Biol. Chem. 267:23797-23805.
16. Roff, C. F., Goldin, E., Comly, M. E., Cooney, A., Brown, A., Vanier, M. T., Miller, S. P. F., Brady, R. O., and Pentchev, P. G. 1991. Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. Dev. Neurosci. 13:315-319.
17. Rodriguez-Lafrasse, C., Rousson, R., Bonnet, J., Pentchev, P. G., Louisot, P., and Vanier, M. T. 1990. Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease. Biochim. Biophys. Acta 1043: 123-128.
18. Phillips, W. A. and Avignan, J. 1963. Inhibition of cholesterol biosynthesis in the rat by 3β-(2-diethylaminoethoxy)androst-5-en-17-one hydrochloride. Proc. Soc. Exp. Biol. 112:233-236.
19. Aikawa, K., Furuchi, T., Fujimoto, Y., Arai, H., and Inoue, K. 1994. Structure-specific inhibition of lysosomal cholesterol transport in macrophages by various steroids. Biochim. Biophys. Acta Lipids Lipid Metab. 1213:127-134.
20. Underwood, K. W., Andemariam, B., McWilliams, G. L., and Liscum, L. 1996. Quantitative analysis of hydrophobic amine inhibition of intracellular cholesterol transport. J. Lipid Res. 37:1556-1568.
21. Pahlman, S., Mamaeva, S., Meyerson, G., Mattsson, M. E. K., Bjelfman, C., Ortoft, E., and Hammerling, U. 1990. Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function. Acta Physiol. Scand. Suppl. 592:25-37.
22. Vaughan, P. F. T., Peers, C., and Walker, J. H. 1995. The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release. Gen. Pharmac. 26:1191-1201.
23. Biedler, J. L., Helson, L., and Spengler, B. A. 1973. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33:2643-2652.
24. Goldstein, J. L., Basu, S. K., and Brown, M. S. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Meth. Enzymol. 98:241-260.
25. Sidhu, H. S., Rastogi, S. A. R., Byers, D. M., Cook, H. W., Palmer, F. B. St. C., and Spence, M. W. 1992. Cultured fibroblasts from patients with Niemann-Pick disease type C and type D exhibit distinct defects in cholesterol esterification. Biochim. Biophys. Acta 1124:29-35.
26. Beisiegel, U., Schneider, W. J., Brown, M. S., and Goldstein, J. L. 1982. Immunoblot analysis of low density lipoprotein receptors in fibroblasts from subjects with familial hypercholesterolemia. J. Biol. Chem. 257:13150-13156.
27. Byers, D. M., Douglas, J.-A., Cook, H. W., Palmer, F. B. S. C., and Ridgway, N. D. 1994. Regulation of intracellular cholesterol metabolism is defective in lymphoblasts from Niemann-Pick type C and type D patients. Biochim. Biophys. Acta Mol. Basis Dis. 1226:173-180.
28. +- and carbacholevoked noradrenaline release from the human neuroblastoma SH-SY5Y. Biochem. J. 297:407-413.
29. Pahlman, S., Ruusala, A. I., Abrahamsson, L., Odelstad, L., and Nilsson, K. 1983. Kinetics and concentration effects of TPA-induced differentiation of cultured human neuroblastoma cells. Cell Differ. 12:165-170.
30. Pörn, M. I. and Slotte, J. P. 1990. Reversible effects of sphingomyelin degradation on cholesterol distribution and metabolism in fibroblasts and transformed neuroblastoma cells. Biochem. J. 271: 121-126.
31. Slotte, J. P. and Bierman, E. L. 1988. Depletion of plasma membrane sphingomyelin rapidly alters the distribution of cholesterol between plasma membranes and intracellular cholesterol pools in cultured fibroblasts. Biochem. J. 250:653-658.
32. Byers, D. M., Morgan, M. W., Cook, H. W., Palmer, F. B. St. C., and Spence, M. W. 1992. Niemann-Pick Type II fibroblasts exhibit impaired cholesterol esterification in response to sphingomyelin hydrolysis. Biochim. Biophys. Acta 1138:20-26.
33. Härmälä, A. -S., Pörn, M. I., Mattjus, P., and Slotte, J. P. 1994. Cholesterol transport from plasma membranes to intracellular membranes is inhibited by 3β-[2-(diethylamino)ethoxy]androst-5-en-17-one. Biochim. Biophys. Acta Lipids Lipid Metab. 1211: 317-325.
34. Tabas, I., Zha, X., Beatini, N., Myers, J. N., and Maxfield, F. R. 1994. The actin cytoskeleton is important for the stimulation of cholesterol esterification by atherogenic lipoproteins in macrophages. J. Biol. Chem. 269:22547-22556.
35. Blanchette-Mackie, E. J., Dwyer, N. K., Amende, L. M., Kruth, H. S., Butler, J. D., Sokol, J., Comly, M. E., Vanier, M. T., August, J. T., Brady, R. O., and Pentchev, P. G. 1988. Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc. Natl. Acad. Sci. USA 85:8022-8026.
36. Turner, N. A., Walker, J. H., Ball, S. G., and Vaughan, P. F. T. 1996. Phorbol ester-enhanced noradrenaline secretion correlates with the presence and activity of protein kinase C-α in human SH-SY5Y neuroblastoma cells. J. Neurochem. 66:2381-2389.
37. Goodall, A. R., Turner, N. A., Walker, J. H., Ball, S. G., and Vaughan, P. F. T. 1997. Activation of protein kinase C-α and translocation of the myristoylated alanine-rich C-kinase substrate correlate with phorbol ester-enhanced noradrenaline release from SH-SY5Y human neuroblastoma cells. J. Neurochem. 68:392-401.
38. Vance, J. E., Pan, D., Campenot, R. B., Bussière, M., and Vance, D. E. 1994. Evidence that the major membrane lipids, except cholesterol, are made in axons of cultured rat sympathetic neurons. J. Neurochem. 62:329-337.
39. Pitas, R. E., Boyles, J. K., Lee, S. H., Hui, D., and Weisgraber, K. H. 1987. Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E (LDL) receptors in the brain. J. Biol. Chem. 262:14352-14360.
40. Ignatius, M. J., Shooter, E. M., Pitas, R. E., and Mahley, R. W. 1987. Lipoprotein uptake by neuronal growth cones in vitro. Science 236:959-962.
41. Lange, Y. and Steck, T. L. 1994. Cholesterol homeostasis. Modulation by amphiphiles. J. Biol. Chem. 269:29371-29374.
42. Sexton, R. C., Panini, S. R., Azran, F., and Rudney, H. 1983. Effects of 3β-[2-(diethylamino)ethoxy]androst-5-ene-17-one on the synthesis of cholesterol and ubiquinone in rat intestinal epithelial cell cultures. Biochemistry 22:5687-5692.
43. Jeng, I., Klemm, N., and Samson, L. 1985. Effect of a hypercholesterolemic agent on cholesteryl ester metabolism in glioblastoma cells. Biochem. Pharmacol. 34:1305-1309.
44. Brown, M. S. and Goldstein, J. L. 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340.
45. Casciola, L. A. F., van der Westhuyzen, D. R., Gevers, W., and Coetzee, G. A. 1988. Low density lipoprotein receptor degradation is influenced by a mediator protein(s) with a rapid turnover rate, but is unaffected by receptor up- or down- regulation. J. Lipid Res. 29:1481-1489.
46. Mazzone, T., Basheeruddin, K., Ping, L., Frazer, S., and Getz, G. S. 1989. Mechanism of the growth-related activation of the low density lipoprotein receptor pathway. J. Biol. Chem. 264:1787-1792.
47. Bastiaanse, E. M. L., Höld, K. M., and Van der Laarse, A. 1997. The effect of membrane cholesterol content on ion transport processes in plasma membranes. Cardiovasc. Res. 33:272-283.